imputed SNPs variant
Evidence from:
primary |
all sources
Related entities (6)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| imputed SNPs | risk_factor_for | Alzheimer's disease | 0.001 | 1 |
| imputed SNPs | associated_with | cases | — | 1 |
| imputed SNPs | associated_with | controls | — | 1 |
| imputed SNPs | interacts_with | SNP | — | 1 |
| meta-analysis | interacts_with | imputed SNPs | — | 1 |
| SNP | interacts_with | imputed SNPs | — | 1 |
Mentioned in (7)
Papers in which this entity is mentioned.
- BridgePRS leverages shared genetic effects across ancestries to increase polygenic risk score portability. (2024)
- Development and validation of a trans-ancestry polygenic risk score for type 2 diabetes in diverse populations. (2022)
- KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex. (2016)
- Peroxisome proliferator-activated receptors α and γ are linked with alcohol consumption in mice and withdrawal and dependence in humans. (2015)
- In search of rare variants: preliminary results from whole genome sequencing of 1,325 individuals with psychophysiological endophenotypes. (2014)
- Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies. (2011)
- A new statistic to evaluate imputation reliability. (2010)
Merged raw entities (2)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| imputed snps | variant | 5 | 5 |
| imputed variants | variant | 2 | 2 |